Pursuant to the regulation 39(3) of SEBI (Listing Obligation and Disclosure Requirements) Regulation 2015, Regulation, Sandu Pharmaceuticals has informed that Linkintime India, the Registrar and Share Transfer Agent (RTA) of the Company has stopped Transfer on receipt of the request for Duplicate issue of Shares from the shareholder, Jitendra M Shah (Folio No: J02648), further details regarding the same as enclosed.
The above information is a part of company’s filings submitted to BSE.